Skip to main content

Boxer Capital, LLC

SEC CIK
0001465837
Latest filing
Feb 14, 2025

ENGN holding history

enGene Therapeutics Inc. in every 13F filed by Boxer Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ENGN overviewAll 13F holders of ENGNFull Q4 2024 holdings

Shares (Q4 2024)
0
Sold out in Q4 2024
Value
$0
% of portfolio
0.0%
Quarters held
3
Since Q1 2024
Holdings of ENGN by Boxer Capital, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20240$00.0%−727,900−100.0%Sold outHolders
Q3 2024727,900$4.80M0.2%00.0%UnchangedHolders
Q2 2024727,900$6.86M0.4%00.0%UnchangedHolders
Q1 2024727,900$12.3M0.6%+727,900NewHolders